Is Revolution Medicines a Good Stock to Own?
Though it’s still quite early in the year, pharmaceutical startup…
Sell
21
AKBA Quote, Financials, Valuation and Earnings
Last price:
$1.36
Seasonality move
:
-12.3%
Day range:
$1.34 - $1.41
52-week range:
$1.31 - $4.08
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.52x
P/B ratio:
8.68x
Volume:
2.8M
Avg. volume:
3M
1-year change:
-29.53%
Market cap:
$360.9M
Revenue:
$160.2M
EPS (TTM):
-$0.08
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $294.6M | $211.7M | $292.5M | $194.6M | $160.2M | |
| Revenue Growth (YoY) | -12.05% | -28.33% | 38.19% | -33.46% | -17.7% | |
| Cost of Revenues | $296.5M | $152.6M | $87.2M | $75.7M | $68.8M | |
| Gross Profit | -$1.8M | $59.1M | $205.3M | $118.9M | $91.3M | |
| Gross Profit Margin | -0.62% | 27.9% | 70.18% | 61.09% | 57.03% | |
| R&D Expenses | $218.5M | $145.9M | $128.3M | $61.5M | $32M | |
| Selling, General & Admin | $154.1M | $177.6M | $141.8M | $103.5M | $109.8M | |
| Other Inc / (Exp) | $1.9M | $2.4M | -$13.7M | $182K | -$811K | |
| Operating Expenses | $376M | $323.6M | $270.1M | $165M | $141.8M | |
| Operating Income | -$377.8M | -$264.5M | -$64.8M | -$46.1M | -$50.4M | |
| Net Interest Expenses | $8.9M | $19.9M | $15.7M | $6M | $18.2M | |
| EBT. Incl. Unusual Items | -$384.8M | -$282M | -$94.2M | -$51.9M | -$69.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$384.8M | -$282M | -$94.2M | -$51.9M | -$69.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$384.8M | -$282M | -$94.2M | -$51.9M | -$69.4M | |
| Basic EPS (Cont. Ops) | -$2.78 | -$1.70 | -$0.52 | -$0.28 | -$0.33 | |
| Diluted EPS (Cont. Ops) | -$2.78 | -$1.70 | -$0.52 | -$0.28 | -$0.33 | |
| Weighted Average Basic Share | $138.5M | $165.9M | $182.8M | $187.5M | $210.9M | |
| Weighted Average Diluted Share | $138.5M | $165.9M | $182.8M | $187.5M | $210.9M | |
| EBITDA | -$343.1M | -$228.4M | -$29.6M | -$4.2M | -$8.7M | |
| EBIT | -$377.8M | -$264.5M | -$64.8M | -$46.1M | -$50.4M | |
| Revenue (Reported) | $294.6M | $211.7M | $292.5M | $194.6M | $160.2M | |
| Operating Income (Reported) | -$377.8M | -$264.5M | -$64.8M | -$46.1M | -$50.4M | |
| Operating Income (Adjusted) | -$377.8M | -$264.5M | -$64.8M | -$46.1M | -$50.4M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $48.8M | $48.7M | $42M | $37.4M | $58.8M | |
| Revenue Growth (YoY) | -18.72% | -0.09% | -13.69% | -10.98% | 57.01% | |
| Cost of Revenues | $10.4M | $38.7M | $18.4M | $14.5M | $9.7M | |
| Gross Profit | $38.3M | $10M | $23.6M | $22.9M | $49.1M | |
| Gross Profit Margin | 78.63% | 20.57% | 56.23% | 61.2% | 83.49% | |
| R&D Expenses | $40M | $27.6M | $12.9M | $8.1M | $14.6M | |
| Selling, General & Admin | $47.2M | $32.6M | $23.6M | $27.3M | $30M | |
| Other Inc / (Exp) | $427K | $81K | -$212K | -$873K | -- | |
| Operating Expenses | $87.2M | $60.2M | $36.5M | $35.4M | $44.6M | |
| Operating Income | -$48.9M | -$50.2M | -$12.9M | -$12.5M | $4.4M | |
| Net Interest Expenses | $5.1M | $4M | $1.4M | $6.7M | $4.7M | |
| EBT. Incl. Unusual Items | -$59.5M | -$54.1M | -$14.5M | -$20M | $1.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | $615K | |
| Net Income to Company | -$59.5M | -$54.1M | -$14.5M | -$20M | $540K | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$59.5M | -$54.1M | -$14.5M | -$20M | $540K | |
| Basic EPS (Cont. Ops) | -$0.34 | -$0.29 | -$0.08 | -$0.10 | $0.00 | |
| Diluted EPS (Cont. Ops) | -$0.34 | -$0.29 | -$0.08 | -$0.10 | $0.00 | |
| Weighted Average Basic Share | $173.8M | $183.9M | $188.3M | $210.3M | $264.8M | |
| Weighted Average Diluted Share | $173.8M | $183.9M | $188.3M | $210.3M | $274.4M | |
| EBITDA | -$39.9M | -$40.8M | -$3.5M | -$3.1M | $4.8M | |
| EBIT | -$48.9M | -$50.2M | -$12.9M | -$12.5M | $4.4M | |
| Revenue (Reported) | $48.8M | $48.7M | $42M | $37.4M | $58.8M | |
| Operating Income (Reported) | -$48.9M | -$50.2M | -$12.9M | -$12.5M | $4.4M | |
| Operating Income (Adjusted) | -$48.9M | -$50.2M | -$12.9M | -$12.5M | $4.4M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $210.7M | $294.5M | $193.5M | $169.9M | $225.1M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $162.3M | $137.5M | -- | $63M | $52.8M | |
| Gross Profit | $48.4M | $156.9M | $81.8M | $106.9M | $172.3M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $153.9M | $125.8M | $84.4M | $34.2M | $42M | |
| Selling, General & Admin | $173.1M | $156.6M | $108.6M | $107.4M | $112.5M | |
| Other Inc / (Exp) | $2.6M | -$12.3M | -$1.3M | $1.5M | -- | |
| Operating Expenses | $327M | $282.4M | $138.3M | $141.6M | $154.6M | |
| Operating Income | -$278.6M | -$125.5M | -$56.6M | -$34.7M | $17.7M | |
| Net Interest Expenses | $17.2M | $19.1M | $6.2M | $12.7M | $26.2M | |
| EBT. Incl. Unusual Items | -$299.2M | -$156.9M | -$61.8M | -$46M | -$15.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | $615K | |
| Net Income to Company | -$299.2M | -$158M | -$58.6M | -$46M | -$15.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$299.2M | -$156.9M | -$61.8M | -$46M | -$15.9M | |
| Basic EPS (Cont. Ops) | -$1.91 | -$0.88 | -$0.33 | -$0.22 | -$0.08 | |
| Diluted EPS (Cont. Ops) | -$1.90 | -$0.88 | -$0.33 | -$0.22 | -$0.08 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$243.7M | -$89.3M | -$19.9M | $2.8M | $32.2M | |
| EBIT | -$278.6M | -$125.5M | -$56.6M | -$34.7M | $17.7M | |
| Revenue (Reported) | $210.7M | $294.5M | $193.5M | $169.9M | $225.1M | |
| Operating Income (Reported) | -$278.6M | -$125.5M | -$56.6M | -$34.7M | $17.7M | |
| Operating Income (Adjusted) | -$278.6M | -$125.5M | -$56.6M | -$34.7M | $17.7M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $154M | $236.8M | $138.4M | $113.7M | $178.6M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $97.5M | $89.5M | $56.7M | $43.9M | $27.9M | |
| Gross Profit | $56.5M | $147.3M | $81.8M | $69.7M | $150.7M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $117.8M | $96.6M | $52M | $24.7M | $34.8M | |
| Selling, General & Admin | $130.2M | $110.8M | $77.2M | $81.1M | $83.9M | |
| Other Inc / (Exp) | $1.9M | -$12.9M | -$476K | $810K | -$6.6M | |
| Operating Expenses | $249.6M | $207.4M | $129.2M | $105.9M | $118.6M | |
| Operating Income | -$193.2M | -$60.1M | -$47.4M | -$36.1M | $32.1M | |
| Net Interest Expenses | $14.9M | $14.1M | $4.6M | $11.3M | $19.4M | |
| EBT. Incl. Unusual Items | -$212.2M | -$87.1M | -$52.5M | -$46.6M | $7.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | $615K | |
| Net Income to Company | -$212.2M | -$88.2M | -$52.5M | -$46.6M | $6.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$212.2M | -$87.1M | -$52.5M | -$46.6M | $6.9M | |
| Basic EPS (Cont. Ops) | -$1.30 | -$0.48 | -$0.28 | -$0.22 | $0.03 | |
| Diluted EPS (Cont. Ops) | -$1.30 | -$0.49 | -$0.28 | -$0.22 | $0.03 | |
| Weighted Average Basic Share | $488.9M | $547.1M | $559.9M | $625M | $762.8M | |
| Weighted Average Diluted Share | $488.9M | $553.9M | $559.9M | $625M | $787.1M | |
| EBITDA | -$163.7M | -$33M | -$19.6M | -$7.9M | $33M | |
| EBIT | -$191.7M | -$60.1M | -$47.4M | -$36.1M | $32.1M | |
| Revenue (Reported) | $154M | $236.8M | $138.4M | $113.7M | $178.6M | |
| Operating Income (Reported) | -$193.2M | -$60.1M | -$47.4M | -$36.1M | $32.1M | |
| Operating Income (Adjusted) | -$191.7M | -$60.1M | -$47.4M | -$36.1M | $32.1M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $228.7M | $149.8M | $90.5M | $42.9M | $51.9M | |
| Short Term Investments | $40M | -- | -- | -- | -- | |
| Accounts Receivable, Net | $26.9M | $55.9M | $41.1M | $39.3M | $34.4M | |
| Inventory | $61M | $36.6M | $21.6M | $15.7M | $16.2M | |
| Prepaid Expenses | -- | -- | -- | $14.5M | $4M | |
| Other Current Assets | $14.9M | $33.1M | $32.9M | $5.8M | $7.3M | |
| Total Current Assets | $371.4M | $271.1M | $185.2M | $118.1M | $113.8M | |
| Property Plant And Equipment | $35.5M | $40.6M | $34.4M | $16M | $10.4M | |
| Long-Term Investments | -- | $2M | $2.7M | $1.7M | $1.7M | |
| Goodwill | $55.1M | $59M | $59M | $59M | $59M | |
| Other Intangibles | $144.2M | $108.1M | $72.1M | $36M | -- | |
| Other Long-Term Assets | $38M | $50.4M | $5.4M | $12.4M | $37.4M | |
| Total Assets | $644.1M | $529.3M | $356.1M | $241.7M | $220.7M | |
| Accounts Payable | $41.3M | $33.6M | $18M | $14.6M | $15.2M | |
| Accrued Expenses | $87.3M | $73M | $18.5M | $22.1M | $24M | |
| Current Portion Of Long-Term Debt | -- | $97.5M | $32M | $17.5M | -- | |
| Current Portion Of Capital Lease Obligations | $5.3M | $4.8M | $4.7M | $4.5M | $5.4M | |
| Other Current Liabilities | -- | -- | $6.6M | $4.6M | $6.1M | |
| Total Current Liabilities | $187.1M | $261.1M | $129.5M | $99.9M | $80.9M | |
| Long-Term Debt | $96.4M | $86.8M | $120.5M | $80.1M | $179M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $396.5M | $455.3M | $350.8M | $272.3M | $269.9M | |
| Common Stock | $1K | $1K | $2K | $2K | $2K | |
| Other Common Equity Adj | $13K | $6K | $6K | $6K | $6K | |
| Common Equity | $247.6M | $74M | $5.2M | -$30.6M | -$49.2M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $247.6M | $74M | $5.2M | -$30.6M | -$49.2M | |
| Total Liabilities and Equity | $644.1M | $529.3M | $356.1M | $241.7M | $220.7M | |
| Cash and Short Terms | $268.7M | $149.8M | $90.5M | $42.9M | $51.9M | |
| Total Debt | $96.4M | $184.3M | $152.5M | $99.7M | $189.3M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $207.2M | $144.8M | $46.5M | $34M | $168.1M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $53.1M | $25M | $22.6M | $32.2M | $66.2M | |
| Inventory | $33.7M | $40M | $18.4M | $20.5M | $18.6M | |
| Prepaid Expenses | -- | -- | -- | $7.2M | -- | |
| Other Current Assets | $39.5M | $29.6M | $22M | $6.2M | -- | |
| Total Current Assets | $330.1M | $237.5M | $109.6M | $100.1M | $258.3M | |
| Property Plant And Equipment | $30.4M | $36M | $17.4M | $11.8M | $6.3M | |
| Long-Term Investments | -- | -- | $1.6M | $1.7M | -- | |
| Goodwill | $55.1M | $55.1M | $59M | $59M | -- | |
| Other Intangibles | $117.1M | $81.1M | $45.1M | $9M | -- | |
| Other Long-Term Assets | $69.6M | $26.3M | $3.9M | $27.1M | -- | |
| Total Assets | $602.3M | $435.9M | $235M | $207.1M | $364.2M | |
| Accounts Payable | $28.8M | $19.7M | $9M | $13.5M | $10.1M | |
| Accrued Expenses | $94.7M | $57.9M | $17.8M | $17.7M | -- | |
| Current Portion Of Long-Term Debt | -- | $65.9M | $8M | -- | -- | |
| Current Portion Of Capital Lease Obligations | $5.7M | $4.3M | $4.9M | $5.3M | -- | |
| Other Current Liabilities | -- | $13.7M | $5.6M | $3M | -- | |
| Total Current Liabilities | $189.2M | $188M | $79.7M | $65.7M | $133.4M | |
| Long-Term Debt | $168.6M | $88.9M | $100.9M | $183.6M | $178.9M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $465.1M | $422M | $274.4M | $257.5M | $322.6M | |
| Common Stock | $2K | $2K | $2K | $2K | $2K | |
| Other Common Equity Adj | $6K | $6K | $6K | $6K | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $137.2M | $13.9M | -$39.4M | -$50.4M | $41.6M | |
| Total Liabilities and Equity | $602.3M | $435.9M | $235M | $207.1M | $364.2M | |
| Cash and Short Terms | $207.2M | $144.8M | $46.5M | $34M | $168.1M | |
| Total Debt | $174.3M | $154.9M | $108.9M | $185.8M | $208.4M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$384.8M | -$282M | -$94.2M | -$51.9M | -$69.4M | |
| Depreciation & Amoritzation | $34.7M | $36.1M | $35.3M | $41.8M | $41.7M | |
| Stock-Based Compensation | $24.5M | $22.7M | $17.8M | $9.3M | $7.8M | |
| Change in Accounts Receivable | $11.7M | -$24M | $11.3M | $994K | $4M | |
| Change in Inventories | $6.2M | -$24.9M | $19.1M | -$2.5M | -$28.4M | |
| Cash From Operations | -$110.4M | -$253M | -$73.2M | -$23.4M | -$40.7M | |
| Capital Expenditures | $317K | $59K | $114K | -- | $33K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$40M | $39.9M | -$114K | -- | -$33K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $20M | -- | -- | -- | $45M | |
| Long-Term Debt Repaid | -- | -- | -$33M | -$32M | -$37.1M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | $44.8M | $40M | -- | -- | |
| Cash From Financing | $231.7M | $133.7M | $14.6M | -$25.2M | $49.7M | |
| Beginning Cash (CF) | $149.8M | $149.8M | $90.5M | $42.9M | $51.9M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $81.3M | -$79.3M | -$58.7M | -$48.6M | $9M | |
| Ending Cash (CF) | $231.1M | $70.5M | $31.8M | -$5.7M | $60.8M | |
| Levered Free Cash Flow | -$110.7M | -$253M | -$73.3M | -$23.4M | -$40.7M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$59.5M | -$54.1M | -$14.5M | -$20M | $540K | |
| Depreciation & Amoritzation | $9M | $10.6M | $10.4M | $9.4M | $318K | |
| Stock-Based Compensation | $5.6M | $3.4M | $1.8M | $1.6M | $3.2M | |
| Change in Accounts Receivable | -$14.7M | $58.7M | -$3M | -$2.4M | $6.2M | |
| Change in Inventories | $428K | -$1M | -$1.6M | -$545K | $6.9M | |
| Cash From Operations | -$56.3M | $33.8M | -$7.2M | -$6.7M | $28.1M | |
| Capital Expenditures | -- | -- | -- | $2K | $77K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -$2K | -$77K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -$33M | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -$522K | -- | |
| Cash From Financing | $16.5M | -$32.9M | $50K | $1.2M | $1.1M | |
| Beginning Cash (CF) | $207.2M | $144.8M | $46.5M | $34M | $168.1M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$39.8M | $868K | -$7.1M | -$5.5M | $29.1M | |
| Ending Cash (CF) | $167.4M | $145.6M | $39.4M | $28.5M | $197.3M | |
| Levered Free Cash Flow | -$56.3M | $33.8M | -$7.2M | -$6.7M | $28M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$299.2M | -$158M | -$58.6M | -$46M | -$15.9M | |
| Depreciation & Amoritzation | $34.8M | $37.3M | $35.2M | $41.8M | $14.5M | |
| Stock-Based Compensation | $24.2M | $19.4M | $10.8M | $7.6M | $9.8M | |
| Change in Accounts Receivable | -$25.2M | $27.1M | $677K | -$9.6M | -$36.3M | |
| Change in Inventories | -$35.5M | $5M | $33.7M | -$31.7M | -$14.2M | |
| Cash From Operations | -$220.9M | -$81.3M | -$75.8M | -$38.5M | $32.4M | |
| Capital Expenditures | $376K | $114K | -- | $31K | $223K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $99.6M | -$114K | -- | -$31K | -$51K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | $45M | -- | |
| Long-Term Debt Repaid | -- | -$33M | -$24M | -$45.1M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | $40M | -- | -- | -- | |
| Cash From Financing | $158.8M | $20M | -$23.9M | $26M | $100.1M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $37.5M | -$61.4M | -$99.7M | -$12.5M | $132.4M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$221.3M | -$81.4M | -$75.8M | -$38.5M | $32.2M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$212.2M | -$88.2M | -$52.5M | -$46.6M | $6.9M | |
| Depreciation & Amoritzation | $28.1M | $28.3M | $28.2M | $28.2M | $948K | |
| Stock-Based Compensation | $18.1M | $14.8M | $7.8M | $6.1M | $8.1M | |
| Change in Accounts Receivable | -$22.8M | $28.3M | $17.7M | $7.1M | -$33.2M | |
| Change in Inventories | -$35.3M | -$5.4M | $9.2M | -$19.9M | -$5.7M | |
| Cash From Operations | -$190.2M | -$18.5M | -$21.1M | -$36.2M | $36.9M | |
| Capital Expenditures | $59K | $114K | -- | $31K | $221K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $39.9M | -$114K | -- | -$31K | -$49K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | $45M | $10M | |
| Long-Term Debt Repaid | -- | -$33M | -$24M | -$37.1M | -$462K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $44.8M | $40M | -- | -$1.3M | -$63K | |
| Cash From Financing | $128.3M | $14.6M | -$23.9M | $27.3M | $77.8M | |
| Beginning Cash (CF) | $693.1M | $463.2M | $157.1M | $115.5M | $418.8M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$21.9M | -$4M | -$45M | -$8.9M | $114.6M | |
| Ending Cash (CF) | $671.3M | $459.2M | $112.1M | $106.6M | $533.4M | |
| Levered Free Cash Flow | -$190.2M | -$18.6M | -$21.1M | -$36.2M | $36.6M | |
Related Companies
Get AKBA Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
AKBA
Sector
P/E ratio
--
23.89x
PEG ratio
-0.51x
-0.01x
P/B ratio
8.68x
1.81x
Price / LTM sales
1.52x
1.59x
Growth Metrics
AKBA
Sector
Revenue growth
57.01%
4.35%
Earnings growth
102.1%
9.8%
Revenue (5-year growth)
-13.72%
6.41%
Earnings forecast
$0.02
-$0.18
Profitability
AKBA
Sector
Profitability FY 2024
$91.3M
$3.2M
Return on invested capital
-7.86%
-32.76%
Return on assets
-5.49%
-29.32%
Return on equity
--
-38.6%
Earnings Date
Last Earnings Date
Nov
10
Next Earnings Date
Mar
12
Estimated Next Earnings Date
Feb
9
Balance Sheet
AKBA
Sector
Total cash
$168.1M
$25.4M
Short term investments
--
$25.1M
Total assets
$220.7M
$74.7M
Long term debt
$208.4M
$3.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Has Vistra Stock Gone Up?
Integrated power generation business Vistra (NYSE:VST) surprised investors recently when…
Why Is Amkor Stock Up So Much?
Semiconductor packaging and testing major Amkor (NASDAQ:AMKR) has started 2026…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Sell
48
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
75
AGX alert for Jan 17
Argan, Inc. [AGX] is up 16.4% over the past day.
Buy
80
ASTS alert for Jan 17
AST Spacemobile, Inc. [ASTS] is up 14.32% over the past day.
Buy
84
IREN alert for Jan 17
IREN Ltd. [IREN] is up 11.35% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
